-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Y-mAbs Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q2 2024.
- Y-mAbs Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.44M, a 4.9% decline year-over-year.
- Y-mAbs Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $19.3M, a 19.8% increase from 2020.
- Y-mAbs Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $16.1M, a 246% increase from 2019.
- Y-mAbs Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $4.66M, a 237% increase from 2018.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)